Your browser doesn't support javascript.
loading
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.
Roy, D G; Geoffroy, K; Marguerie, M; Khan, S T; Martin, N T; Kmiecik, J; Bobbala, D; Aitken, A S; de Souza, C T; Stephenson, K B; Lichty, B D; Auer, R C; Stojdl, D F; Bell, J C; Bourgeois-Daigneault, M-C.
Afiliação
  • Roy DG; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Geoffroy K; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Marguerie M; CRCHUM: "Centre Hospitalier de l'Université de Montréal" Research Centre, Montreal, QC, Canada.
  • Khan ST; "Institut du cancer de Montréal", Montreal, QC, Canada.
  • Martin NT; "Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal", Montreal, QC, Canada.
  • Kmiecik J; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Bobbala D; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Aitken AS; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • de Souza CT; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Stephenson KB; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Lichty BD; Turnstone Biologics, Ottawa, ON, Canada.
  • Auer RC; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
  • Stojdl DF; Turnstone Biologics, Ottawa, ON, Canada.
  • Bell JC; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Bourgeois-Daigneault MC; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Nat Commun ; 12(1): 2626, 2021 05 11.
Article em En | MEDLINE | ID: mdl-33976179

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Vírus Oncolíticos / Terapia Viral Oncolítica / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Vírus Oncolíticos / Terapia Viral Oncolítica / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article